General American Investors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

General American Investors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-62,583	Closed	-$41.7K	–	76
2023 Q3	$41.7K	Hold	62,583	–	–	﹤0.01%	69
2023 Q2	$206K	Hold	62,583	–	–	0.02%	66
2023 Q1	$569K	Hold	62,583	–	–	0.05%	59
2022 Q4	$734K	Hold	62,583	–	–	0.07%	57
2022 Q3	$1.32M	Hold	62,583	–	–	0.14%	56
2022 Q2	$1.52M	Hold	62,583	–	–	0.15%	57
2022 Q1	$3.12M	Hold	62,583	–	–	0.25%	59
2021 Q4	$4.39M	Hold	62,583	–	–	0.34%	56
2021 Q3	$5.84M	Hold	62,583	–	–	0.5%	55
2021 Q2	$6.29M	Buy	62,583 +1,666	+3%	+$162K	0.53%	56
2021 Q1	$5.68M	Buy	60,917 +6,391	+12%	+$648K	0.53%	52
2020 Q4	$4.5M	Buy	54,526 +21,173	+63%	+$1.81M	0.44%	52
2020 Q3	$2.86M	Sell	33,353 -5,203	-13%	-$606K	0.33%	54
2020 Q2	$3.59M	Sell	38,556 -5,000	-11%	-$275K	0.45%	53
2020 Q1	$1.24M	Hold	43,556	–	–	0.17%	62
2019 Q4	$1.8M	Sell	43,556 -28,919	-40%	-$633K	0.17%	63
2019 Q3	$1.02M	Hold	72,475	–	–	0.1%	64
2019 Q2	$2.54M	Buy	72,475 +13,660	+23%	+$741K	0.24%	65
2019 Q1	$3.3M	Hold	58,815	–	–	0.33%	60
2018 Q4	$2.82M	Buy	58,815 +30,000	+104%	+$1.65M	0.3%	60
2018 Q3	$2.09M	Hold	28,815	–	–	0.18%	65
2018 Q2	$2.38M	Buy	28,815 +8,815	+44%	+$851K	0.22%	65
2018 Q1	$2.1M	Hold	20,000	–	–	0.2%	66
2017 Q4	$2.56M	Buy	+20,000	New	+$2.46M	0.25%	63

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

General American Investors's VBIV Position: Q4 2023 in Review

General American Investors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2023, closing a stake of 62,583 shares — an estimated $41.7K sold.

General American Investors first reported a position in VBIV in Q4 2017 and held it in 24 quarters. The position peaked at $6.29M in Q2 2021. 39 funds tracked by Wall St. Rank hold VBIV as of Q4 2023.

General American Investors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2023 after selling out during the quarter.
General American Investors sold 62,583 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2023, an estimated $41.7K.
General American Investors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 24 quarters.
General American Investors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $6.29M in Q2 2021.
39 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2023.

Based on General American Investors's 13F filing for Q4 2023, filed 13 Feb 2024.